Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Breakout Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 29
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 21
Rounds per year 4.14
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 2
Key employees 3
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Life Science
  • Therapeutics
  • Medical
  • Machine Learning
Summary

Breakout Ventures is the famous VC, which was founded in 2016. The leading representative office of defined VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.

The typical case for the fund is to invest in rounds with 6 participants. Despite the Breakout Ventures, startups are often financed by Dolby Family Ventures, Lux Capital, Data Collective DCVC. The meaningful sponsors for the fund in investment in the same round are Dolby Family Ventures, Blackhorn Ventures, Western Technology Investment. In the next rounds fund is usually obtained by Dolby Family Ventures, Western Technology Investment, Vulcan Capital.

The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Breakout Ventures is 10-50 millions dollars. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Breakout Ventures performs on 18 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2019. The increased amount of exits for fund were in 2019.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 1 or 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Modern Meadow, Phylagen, Checkerspot Among the most successful fund investment fields, there are Pharmaceutical, Health Diagnostics.

We also calculated 3 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Breakout Ventures:
Typical Co-investors
Breakout Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Breakout Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Gen-Probe California, San Diego, United States
Generac Power Systems United States, Waukesha, Wisconsin
GUS Holdings -
HEROZ Japan, Tokyo
Infield Capital Boulder, Colorado, United States
Jinsanban Touzi China, Huangpu, Shanghai
Josep Carreras Leukaemia Research Institute Badalona, Catalonia, Spain
Quadient Bagneux, France, Ile-de-France
Raymonds Capital, LLC -
Shanghai Dingmo Touzi Guanli Zhongxin (Limited Partnership) -
Sovereign Brands -
Tequity -
The Topol Group -
Triodos Investment Management The Netherlands, Utrecht, Zeist
Tsukuba Institute of Research Ibaraki, Japan, Osaka Prefecture
Vaultier7 England, London, United Kingdom
W&H Dentalwerk Austria, Bürmoos, Salzburg
Yadea China, Jiangsu, Wuxi Shi

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

TFC Therapeutics

Biopharma
Biotechnology
Medical
17 Aug 2023 Nyack, New York, United States

A-Alpha Bio

Biotechnology
Health Care
Product Design
$22M25 Jul 2023 Seattle, Washington, United States

Parallel Bio

Biotechnology
Life Science
Pharmaceutical
Therapeutics
$4M20 Dec 2022 Los Angeles, California, United States

EnPlusOne Biosciences

Biotechnology
Therapeutics
$12M30 Sep 2022 Watertown, Massachusetts, United States

Canaery

Information Technology
Machine Learning
Software
$4M01 Jul 2022 -

Opus 12

Chemical
Environmental Consulting
Fuel
Oil and Gas
$130M29 Jun 2022 Berkeley, California, United States

Surf Bio

Biotechnology
Pharmaceutical
$16M12 Apr 2022 Palo Alto, California, United States

Phantom Neuro

Biotechnology
Medical
$3M25 Mar 2022 Austin, Texas, United States

Zymochem

Biotechnology
Chemical
Industrial
$4M08 Dec 2021 California, United States
News
Twelve, Formerly Opus 12, Secures $57 Million in Series A Funding Led by Capricorn and Carbon Direct

– Carbon transformation startup Twelve has raised $57 million in Series A funding.
– The round was led by Capricorn Technology Impact Fund and Carbon Direct Capital Management.
– Seed round lead DCVC, as well as Munich Re Ventures, Microsoft Climate Innovation Fund, Breakout Ventures, and Evok Innovations also participated in the round.
– Twelve is pioneering a new market category called carbon transformation with its proprietary catalyst technology that transforms CO2 into critical chemicals, materials and fuels that are conventionally made from fossil fuels.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Breakout Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 29
Average round size 26M
Rounds per year 4.14
Peak activity year 2022
Lead investments 2
Follow on index 0.28
Exits 2
Group Appearance index 0.97

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

TFC Therapeutics

Biopharma
Biotechnology
Medical
17 Aug 2023 Nyack, New York, United States

A-Alpha Bio

Biotechnology
Health Care
Product Design
$22M25 Jul 2023 Seattle, Washington, United States

Parallel Bio

Biotechnology
Life Science
Pharmaceutical
Therapeutics
$4M20 Dec 2022 Los Angeles, California, United States

EnPlusOne Biosciences

Biotechnology
Therapeutics
$12M30 Sep 2022 Watertown, Massachusetts, United States

Canaery

Information Technology
Machine Learning
Software
$4M01 Jul 2022 -

Opus 12

Chemical
Environmental Consulting
Fuel
Oil and Gas
$130M29 Jun 2022 Berkeley, California, United States

Surf Bio

Biotechnology
Pharmaceutical
$16M12 Apr 2022 Palo Alto, California, United States

Phantom Neuro

Biotechnology
Medical
$3M25 Mar 2022 Austin, Texas, United States

Zymochem

Biotechnology
Chemical
Industrial
$4M08 Dec 2021 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: